Business Context and Reporting Period
This Form 8-K reports on the results of Evommune, Inc.'s 2026 Annual Meeting of Stockholders held on June 2, 2026. The company is incorporated in Delaware and its common stock trades on the New York Stock Exchange under the symbol EVMN. The filing details the voting outcomes for the election of directors and the ratification of the independent auditor.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Voting Results
The filing discloses the following material outcomes from the Annual Meeting:
- Election of Directors: Two nominees were elected to the Board of Directors for terms ending at the 2029 Annual Meeting:
- Luis Pe?a: Received 21,859,596 votes "For" and 1,949,148 votes "Withheld".
- Eugene Bauer, M.D.: Received 23,637,920 votes "For" and 170,824 votes "Withheld".
- Ratification of Auditor: Stockholders approved the selection of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Votes "For": 24,664,299
- Votes "Against": 430
- Votes "Abstain": 29,765
Guidance, Outlook, and Risks
This filing does not provide management commentary, financial guidance, outlook, or specific risk factors. It strictly reports the procedural results of the shareholder vote.
Key Facts for Investor Verification
- Verify the definitive proxy statement filed on April 21, 2026, for detailed biographies of the elected directors and the rationale for the auditor selection.
- Confirm the total number of shares outstanding and the quorum status, as the filing notes a quorum was present but does not list the total shares eligible to vote.
- Note that the company is classified as an emerging growth company.
- Review subsequent filings (e.g., 10-K or 10-Q) for the actual financial performance metrics absent from this 8-K.